openPR Logo
Press release

Biosimulation Market : Global Market Revenue and Share by Manufacturers

08-05-2022 08:36 AM CET | Health & Medicine

Press release from: Transparency Market Research

Biosimulation Market: Introduction

According to the report, the global biosimulation market was valued at US$ 1.8 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Biosimulation can be defined as computer-aided mathematical simulation of biological processes, which form an integral part of the human biology system. Biosimulation is focused on offering model-based prediction of the behavior and the dynamics of biological systems. The growth of the global biosimulation market can be attributed to significant rise in spending on R&D by pharmaceutical and biotechnology companies. Additionally, high cost associated with re-conducting clinical trials, owing to the high failure rate in phase III clinical trials contributes to the adoption of biosimulation in drug discovery and drug development, which, in turn, boosts the growth of the market.

North America dominated the global biosimulation market in terms of revenue in 2019 and the trend is projected to continue during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2020 to 2030. The growth of the market in North America can be attributed to the strong recommendation by the U.S. FDA for adopting biosimulation, increase in adoption of predictive biosimulation in the R&D process, and rise in focus on the development of biosimulation platforms for the development of COVID-19 vaccines.

Read Report Overview- https://www.transparencymarketresearch.com/biosimulation-market.html

Strategic Acquisitions among Key Market Players

Leading players, such as Certara and Simulations Plus, focus on enhancing their market presence by adopting inorganic growth strategies. This, in turn, will enable them to cater the rise in demand and consolidate their position in the biosimulation market. Simulations Plus, a leading player in the biosimulation market acquired Lixoft of Paris, France, in April 2020. Lixoft is focused on designing software solutions for reducing the cost and increasing the success rate of new drug development.

In February 2020, Certara acquired the modelling and biosimulation technology assets from In Silico Biosciences, Inc. The assets acquired include platform of multiple integrated quantitative systems pharmacology (QSP) modules related to brain pathology and physiology.

Enquiry before Buying Biosimulation Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=703

Software Dominated Global Market

In terms of offering type, the software segment is projected to account for major share of the global biosimulation market during the forecast period. The growth of the segment can be attributed to increase in the number of pharmaceutical and biotechnology companies, regulatory agencies, and academic & research institutes employing biosimulation software during the research process of drug discovery and drug development.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=703

Biosimulation Market: Prominent Regions

The global biosimulation market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global biosimulation market in 2019. The U.S. was a major market for biosimulation in the region in 2019. The expansion of the market in the country can be attributed to the presence of leading players, rise in usage of biosimulation technology by pharmaceutical and biotechnology companies, and recommendation of regulatory agencies to employ the biosimulation technology in the drug development process.

The biosimulation market in Asia Pacific is expected to expand at a high CAGR from 2020 to 2030 driven by developing countries such as China and India. Life science research is gaining momentum in countries across Asia, partly due to favorable government policies and high demand for innovative drugs. Additionally, a large and trained talent pool of researchers and engineers coupled with significant computational infrastructure have ensured that the expansion remains at a relatively rapid pace. Furthermore, the biosimulation market is expanding rapidly in China and India despite late entry of industry players in these countries.

Request a Sample of Biosimulation Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=703

Strategic Acquisitions and Partnerships by Key Players to Propel Global Market

The global biosimulation market is fragmented in terms of number of players. Key players operating in the global biosimulation market are Certara, Dassault Systèmes S.A., Schrödinger, Inc., Simulations Plus, Inc., Rhenovia Pharma, Advanced Chemistry Development, Inc., Insilico Biotechnology AG, Physiomics plc, Genedata AG, and Rosa & Co. LLC., among others.

More Trending Reports by Transparency Market Research:

Biomaterials Market- https://www.transparencymarketresearch.com/biomaterials-market.html

Chromatography Systems Market- https://www.transparencymarketresearch.com/chromatography-market.html

Human Reproductive Technologies Market- https://www.transparencymarketresearch.com/human-reproductive-technologies-market.html

Cardiac Prosthetic Devices Market- https://www.transparencymarketresearch.com/cardiac-prosthetic-market.html

Genomics And Proteomics Reagents, Research Kits and Analytical Instruments Market- https://www.transparencymarketresearch.com/proteomics-market.html

Medical Disposables Market- https://www.transparencymarketresearch.com/medical-disposables-market.html

Apheresis Equipment Market - https://www.transparencymarketresearch.com/apheresis-equipment.html

Neuromodulation Devices Market- https://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market : Global Market Revenue and Share by Manufacturers here

News-ID: 2698644 • Views:

More Releases from Transparency Market Research

Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Connectivity / By Application | U.S. • Japan • U.K. • Brazil
Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Co …
The global wireless sensors market is witnessing strong growth momentum, driven by rising digital transformation across industrial, infrastructure, healthcare, and smart city ecosystems. According to industry analysis, the wireless sensors market was valued at US$ 17.4 billion in 2025 and is projected to reach US$ 80.6 billion by 2036, expanding at a robust CAGR of 14.7% during the forecast period from 2026 to 2036. Access an overview of significant conclusions from
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By Distribution Channel | U.S. • Japan • Brazil • U.K.
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By …
The global skin care market continues to demonstrate steady growth, reflecting the increasing integration of skincare into daily health and wellness routines. The market was valued at US$ 195.8 billion in 2025 and is projected to reach US$ 318.1 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=340 The industry growth is
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US$ 132.7 Billion at 7.2% CAGR Driven by Clinical Trial Complexity and Rising R&D Investments
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US …
The global Healthcare Contract Research Outsourcing Market was valued at US$ 61.6 Bn in 2025 and is projected to reach US$ 132.7 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2036. The market's steady expansion reflects the growing reliance of pharmaceutical, biotechnology, and medical device companies on Contract Research Organizations (CROs) to optimize development costs and accelerate time-to-market. In 2025, North America accounted
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach US$ 9.6 Billion by 2036 Driven by HPV Testing, Government Screening Programs, and Molecular Diagnostic Innovations
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach U …
The global cervical cancer diagnostic tests market is on a steady growth trajectory, reflecting the rising global focus on women's health, preventive oncology, and early disease detection. Valued at US$ 5.4 Bn in 2025, the market is projected to reach US$ 9.6 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Cervical cancer remains one of the most common cancers affecting women worldwide,

All 5 Releases


More Releases for Biosimulation

Key Trends Influencing the Growth of the Biosimulation Market in 2025: Innovatio …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Is the Expected CAGR for the Biosimulation Market Through 2025? The size of the biosimulation market has seen a significant increase lately. This market is projected to expand from a total value of $4.47 billion in 2024 to $5.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. The historic
Global Healthcare Expenditure Boosts Biosimulation Market Growth: A Significant …
The Biosimulation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Biosimulation Market Size and Projected Growth Rate? The size of the biosimulation market has expanded significantly in the past few years. Starting from a valuation of $4.47 billion in 2024, it's forecasted to
Primary Catalyst Driving Biosimulation Market Evolution in 2025: Global Healthca …
What market dynamics are playing a key role in accelerating the growth of the biosimulation market? The anticipated rise in global healthcare expenditure is predicted to bolster the biosimulation market throughout the forecast period. The uptick in healthcare expenses is expected to increase spending on drug development, consequently fueling revenue from biosimulation solutions. Currently, biosimulation software is utilized in drug development to imitate diseases. This software enables the conduct of virtual
North America Biosimulation Market
The global biosimulation market is experiencing rapid expansion, driven by advancements in technology and the increasing demand for computational tools that can accelerate drug discovery, clinical trials, and regulatory processes. As of 2023, the market was valued at USD 3.5 billion and is projected to reach USD 14.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 16.90% from 2024 to 2032. Biosimulation, which involves the use of
Global Biosimulation Market Research Report 2023-2029
Biosimulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimulation market is projected to reach US$ 3686.5 million in 2029, increasing from US$ 1580.2 million in 2022, with the CAGR of 12.7% during the period of 2023 to 2029. Demand from Hospital and Scientific Research Institutions are the major drivers for the industry. Global Biosimulation Market: Driven factors and Restrictions factors The research
Biosimulation Technology Market - Precision Modeling, Transformative Insights: B …
Newark, New Castle, USA: The "Biosimulation Technology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Biosimulation Technology Market: https://www.growthplusreports.com/report/biosimulation-technology-market/7766 This latest report researches the industry structure, sales, revenue,